Daniel J. Levangie, President, Surgical Products, 10% Owner at CYTYC CORP (CYTC), sold 35,890 shares at $51.44 ($1.8M) on 2007-10-12, disclosed to the SEC on 2007-10-15.
Scheduled sale ($1.8M) by President, Surgical Products, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2019-08-02 | $5.0M | — | Filing → |
| PODD | SELL | 2016-03-11 | $524K | — | Filing → |
| PODD | SELL | 2016-03-09 | $477K | — | Filing → |